Congenital heart malformations, also known as congenital heart defects (CHDs), encompass a spectrum of structural abnormalities in the heart that manifest at birth, originating during fetal development. These defects impact various components of the heart, including its walls, valves, and blood vessels, leading to disruptions in normal blood flow. The severity of CHDs can vary, with some posing minimal health risks while others demand immediate medical attention. The etiology of congenital heart malformations is multifaceted, involving a complex interplay of genetic factors, environmental influences, or a combination thereof. Recent strides in medical technology have revolutionized the landscape of prenatal screening, enabling the early detection of congenital heart malformations. This breakthrough facilitates timely intervention and treatment strategies, ultimately enhancing patient outcomes. Treatment approaches are diverse, tailored to the specific defect and its severity. They range from pharmaceutical interventions to intricate surgical procedures aimed at rectifying the structural anomalies.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom